Drug
Buffer
Buffer is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
completed250%
active_not_recruiting125%
unknown125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Pain Perception: Lidocaine Rate/Temp/Buffer
NCT02823002
unknownphase_2
A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility
NCT03386552
completednot_applicable
A Pilot Evaluation of Adhesives and How They Are Impacted by Out-put
NCT02610907
completednot_applicable
Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh
NCT01579825
Clinical Trials (4)
Showing 4 of 4 trials
NCT02823002Not Applicable
Pain Perception: Lidocaine Rate/Temp/Buffer
NCT03386552Phase 2
A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility
NCT02610907Not Applicable
A Pilot Evaluation of Adhesives and How They Are Impacted by Out-put
NCT01579825Not Applicable
Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4